Cargando…

Chronic venulectasias secondary to persistent flushing in the setting of a metastatic well-differentiated neuroendocrine tumor

Detalles Bibliográficos
Autores principales:	Pope, Eleanor M., Somers, Kathryn E.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2022
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9294488/ https://www.ncbi.nlm.nih.gov/pubmed/35865723 http://dx.doi.org/10.1016/j.jdcr.2022.06.002

Ejemplares similares

Heart Failure in a Patient With Metastatic Well-Differentiated Neuroendocrine Tumor
por: Henderson, Amy, et al.
Publicado: (2023)

A 17-year-old male with a Small Bowel Neuroendocrine Tumor: flushing differential diagnosis
por: Forero Molina, Maria Alejandra, et al.
Publicado: (2017)

Metastatic well-differentiated neuroendocrine carcinoma of the pancreas: case report and review of literature
por: Martin, Mersadies R, et al.
Publicado: (2009)

A practical proposal on treatment sequencing of metastatic well-differentiated neuroendocrine tumours
por: Perrier, Marine, et al.
Publicado: (2023)

Primary Well-Differentiated Neuroendocrine Tumor of the Kidney
por: Prasad, Vishnu, et al.
Publicado: (2023)

Flush
por: Woolf, Virginia, 1882-1941
Publicado: (1956)

Flush
por: Woolf, Virginia, 1882-1941
Publicado: (1971)

On Flushing
Publicado: (1891)

Flushing
por: Mulley, G. P.
Publicado: (1978)

Phase II study of sunitinib in Japanese patients with unresectable or metastatic, well-differentiated pancreatic neuroendocrine tumor
por: Ito, Tetsuhide, et al.
Publicado: (2013)

CAPTEM in Metastatic Well-Differentiated Intermediate to High Grade Neuroendocrine Tumors: A Single Centre Experience
por: Sahu, Arvind, et al.
Publicado: (2019)

Phase II study of lanreotide autogel in Japanese patients with unresectable or metastatic well-differentiated neuroendocrine tumors
por: Ito, Tetsuhide, et al.
Publicado: (2017)

Values of debulking surgery for unresectable well-differentiated metastatic pancreatic neuroendocrine tumors: a comparative study
por: Huang, Xi-Tai, et al.
Publicado: (2023)

Evaluation of Flushing Ability of Cementing Flushing Fluids
por: Wang, Jingpeng, et al.
Publicado: (2021)

Flushing as atypical initial presentation of functional gallbladder neuroendocrine carcinoma: A case report
por: Jin, Ming, et al.
Publicado: (2020)

Bevacizumab plus octreotide and metronomic capecitabine in patients with metastatic well-to-moderately differentiated neuroendocrine tumors: the xelbevoct study
por: Berruti, Alfredo, et al.
Publicado: (2014)

Streptozocin chemotherapy for advanced/metastatic well-differentiated neuroendocrine tumors: an analysis of a multi-center survey in Japan
por: Aoki, Taku, et al.
Publicado: (2014)

Metastatic well differentiated serotonin-producing pancreatic neuroendocrine tumor with carcinoid heart disease: a case report
por: Kudelka, Matthew R., et al.
Publicado: (2023)

FLUshing in the bathroom
por: Amezcua, Carolina, et al.
Publicado: (2014)

Data Flush
por: Shen, Xiaotong, et al.
Publicado: (2022)

Two well-differentiated pancreatic neuroendocrine tumor mouse models
por: Wong, Chung, et al.
Publicado: (2019)

Novel therapeutics for patients with well-differentiated gastroenteropancreatic neuroendocrine tumors
por: Das, Satya, et al.
Publicado: (2021)

The NETPET Score: Combining FDG and Somatostatin Receptor Imaging for Optimal Management of Patients with Metastatic Well-Differentiated Neuroendocrine Tumors
por: Hindié, Elif
Publicado: (2017)

Transanal Endoscopic Microsurgery for the Treatment of Well-Differentiated Rectal Neuroendocrine Tumors
por: Kim, Hyoung Ran, et al.
Publicado: (2012)

Profile of capecitabine/temozolomide combination in the treatment of well-differentiated neuroendocrine tumors
por: Kotteas, Elias A, et al.
Publicado: (2016)

Clinical and Pathological Features of Primary Renal Well-Differentiated Neuroendocrine Tumor
por: Jiang, Hua, et al.
Publicado: (2022)

Gallbladder primary well-differentiated neuroendocrine tumor: A misdiagnosed case
por: Dammak, Nouha, et al.
Publicado: (2023)

Well‑differentiated neuroendocrine tumor of the right kidney: A case report
por: Yang, Denghao, et al.
Publicado: (2023)

Flushing out neutrophils
por: Bashyam, Hema
Publicado: (2008)

Operation straight flush
por: van Breugel, H, et al.
Publicado: (1967)

Epoprostenol: Flushing or Erythroderma?
por: Martínez-Martínez, María Luisa, et al.
Publicado: (2013)

Unusual paraneoplastic neurological syndrome secondary to a well differentiated pancreatic neuroendocrine tumor: a case report and review of the literature
por: Brizzi, Maria Pia, et al.
Publicado: (2015)

Botulinum Toxin A Alleviates Persistent Erythema and Flushing in Patients with Erythema Telangiectasia Rosacea
por: Yang, Rongli, et al.
Publicado: (2022)

Advances in the Diagnosis and Management of Well-Differentiated Neuroendocrine Neoplasms
por: Hofland, Johannes, et al.
Publicado: (2020)

Observational Study in a Real-World Setting of Targeted Therapy in the Systemic Treatment of Progressive Unresectable or Metastatic Well-Differentiated Pancreatic Neuroendocrine Tumors (pNETs) in France: OPALINE Study
por: Smith, Denis, et al.
Publicado: (2022)

What Lies behind Paraneoplastic Hypercalcemia Secondary to Well-Differentiated Neuroendocrine Neoplasms? A Systematic Review of the Literature
por: Giannetta, Elisa, et al.
Publicado: (2022)

A clinical and radiological objective tumor response with somatostatin analogs (SSA) in well-differentiated neuroendocrine metastatic tumor of the ileum: a case report
por: De Divitiis, Chiara, et al.
Publicado: (2015)

Global microRNA profiling of well-differentiated small intestinal neuroendocrine tumors
por: Li, Su-Chen, et al.
Publicado: (2013)

Well-differentiated neuroendocrine tumor of the stomach: A rare case at an uncommon site
por: Gumuscu, Burak, et al.
Publicado: (2016)

Effect of Endostar combined with chemotherapy in advanced well-differentiated pancreatic neuroendocrine tumors
por: Cheng, Yue-Juan, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_cdkk5ms7kgudtplegjejggn3c7